Published in Annu Rev Immunol on October 04, 2001
Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer (2003) 4.99
A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol (2006) 3.73
The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proc Natl Acad Sci U S A (2005) 2.47
MHC class I: an unexpected role in neuronal plasticity. Neuron (2009) 2.20
Immune epitope database analysis resource. Nucleic Acids Res (2012) 2.09
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A (2012) 1.89
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med (2006) 1.79
Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer. J Proteome Res (2007) 1.56
Tapasin enhances MHC class I peptide presentation according to peptide half-life. Proc Natl Acad Sci U S A (2004) 1.49
Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med (2004) 1.48
Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol (2010) 1.46
Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci U S A (2008) 1.43
ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity (2006) 1.43
Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol (2004) 1.40
Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol (2004) 1.29
A common single nucleotide polymorphism in endoplasmic reticulum aminopeptidase 2 induces a specificity switch that leads to altered antigen processing. J Immunol (2012) 1.27
A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One (2008) 1.26
Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc Natl Acad Sci U S A (2010) 1.25
The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS One (2008) 1.23
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes. J Exp Med (2007) 1.16
Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol (2012) 1.14
Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci U S A (2013) 1.08
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry. Mol Cell Proteomics (2015) 1.05
Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol (2003) 1.05
The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS One (2010) 1.04
Non-conventional sources of peptides presented by MHC class I. Cell Mol Life Sci (2011) 1.03
Production of an antigenic peptide by insulin-degrading enzyme. Nat Immunol (2010) 1.02
MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA. Proc Natl Acad Sci U S A (2012) 1.02
A detailed analysis of the murine TAP transporter substrate specificity. PLoS One (2008) 1.00
Reconstruction of a pathway of antigen processing and class II MHC peptide capture. EMBO J (2007) 0.99
PI31 is a modulator of proteasome formation and antigen processing. Proc Natl Acad Sci U S A (2002) 0.98
HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol (2010) 0.98
Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo. J Immunol (2009) 0.97
Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides. J Virol (2011) 0.95
MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther Adv Vaccines (2014) 0.91
The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing. Mol Cell Proteomics (2011) 0.89
Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics (2010) 0.88
Comparative analysis of sequence features involved in the recognition of tandem splice sites. BMC Genomics (2008) 0.88
ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers. Clin Exp Immunol (2010) 0.87
An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions. J Immunol (2006) 0.87
Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules. J Exp Med (2003) 0.87
Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol (2007) 0.87
Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome. PLoS One (2015) 0.85
Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond. Proc Natl Acad Sci U S A (2010) 0.83
T Cells: Soldiers and Spies-The Surveillance and Control of Effector T Cells by Regulatory T Cells. Clin J Am Soc Nephrol (2015) 0.82
Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J Biol Chem (2013) 0.82
In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice. J Virol (2004) 0.82
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. Proteomics (2011) 0.81
EpicCapo: epitope prediction using combined information of amino acid pairwise contact potentials and HLA-peptide contact site information. BMC Bioinformatics (2012) 0.81
The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies. J Proteomics (2013) 0.80
Bacterial and host factors involved in the major histocompatibility complex class Ib-restricted presentation of Salmonella Hsp 60: novel pathway. Infect Immun (2004) 0.80
Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases. PLoS One (2013) 0.80
MARCH9 mediated-ubiquitination regulates MHC I export from the TGN. Immunol Cell Biol (2017) 0.79
Optimal length transportation hypothesis to model proteasome product size distribution. J Biol Phys (2006) 0.78
Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications. Future Virol (2012) 0.78
An MHC class I immune evasion gene of Marek׳s disease virus. Virology (2014) 0.78
Crystal structure of the N-myristoylated lipopeptide-bound MHC class I complex. Nat Commun (2016) 0.78
ERAAP modulation: A possible novel strategy for cancer immunotherapy? Oncoimmunology (2012) 0.78
Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance. Immunol Rev (2016) 0.78
Coherent expression chromosome cluster analysis reveals differential regulatory functions of amino-terminal and distal parathyroid hormone-related protein domains in prostate carcinoma. J Biomed Biotechnol (2005) 0.77
The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus. Mol Cell Proteomics (2015) 0.77
Modification of Antigen Impacts on Memory Quality after Adenovirus Vaccination. J Immunol (2016) 0.76
A common minimal motif for the ligands of HLA-B*27 class I molecules. PLoS One (2014) 0.75
Decoding sORF translation - from small proteins to gene regulation. RNA Biol (2016) 0.75
Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules. Immunology (2016) 0.75
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. J Immunol (2016) 0.75
Antigen Processing in the Endoplasmic Reticulum Is Monitored by Semi-Invariant αβ TCRs Specific for a Conserved Peptide-Qa-1b MHC Class Ib Ligand. J Immunol (2017) 0.75
Presentation of Cryptic Peptides by MHC Class I Is Enhanced by Inflammatory Stimuli. J Immunol (2016) 0.75
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology. J Vis Exp (2015) 0.75
Immune surveillance obstructed by viral mRNA. Proc Natl Acad Sci U S A (2008) 0.75
A novel unconventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera. Int J Immunopathol Pharmacol (2007) 0.75
LAPTM4B-35 protein is a weak tumor-associated antigen candidate. Exp Ther Med (2013) 0.75
ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules. J Immunol (2016) 0.75
Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA. Immunogenetics (2006) 0.75
Mining for Micropeptides. Trends Cell Biol (2017) 0.75
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35
Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature (2010) 6.06
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 3.14
Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes Dev (2009) 2.46
New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell (2006) 2.34
Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood (2008) 2.06
Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS One (2012) 1.96
In vitro assays misrepresent in vivo lineage potentials of murine lymphoid progenitors. Blood (2010) 1.81
All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev (2005) 1.27
Position-dependent silencing of germline Vß segments on TCRß alleles containing preassembled VßDJßCß1 genes. J Immunol (2010) 0.91
Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. J Exp Med (2013) 0.88